The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease

References

• Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009; 9:799 - 809; http://dx.doi.org/10.1038/nri2653; PMID: 19855405
   PubMed Web of Science ®Google Scholar
• Powell DW. Barrier function of epithelia. Am J Physiol 1981; 241:G275 - 88; PMID: 7032321
   PubMed Web of Science ®Google Scholar
• Laukoetter MG, Bruewer M, Nusrat A. Regulation of the intestinal epithelial barrier by the apical junctional complex. Curr Opin Gastroenterol 2006; 22:85 - 9; http://dx.doi.org/10.1097/01.mog.0000203864.48255.4f; PMID: 16462161
   PubMed Web of Science ®Google Scholar
• Fanning AS, Jameson BJ, Jesaitis LA, Anderson JM. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem 1998; 273:29745 - 53; http://dx.doi.org/10.1074/jbc.273.45.29745; PMID: 9792688
   PubMed Web of Science ®Google Scholar
• Van Itallie CM, Anderson JM. Claudins and epithelial paracellular transport. Annu Rev Physiol 2006; 68:403 - 29; http://dx.doi.org/10.1146/annurev.physiol.68.040104.131404; PMID: 16460278
   PubMed Web of Science ®Google Scholar
• Shen L, Weber CR, Raleigh DR, Yu D, Turner JR. Tight junction pore and leak pathways: a dynamic duo. Annu Rev Physiol 2011; 73:283 - 309; http://dx.doi.org/10.1146/annurev-physiol-012110-142150; PMID: 20936941
   PubMed Web of Science ®Google Scholar
• Shen L, Weber CR, Turner JR. The tight junction protein complex undergoes rapid and continuous molecular remodeling at steady state. J Cell Biol 2008; 181:683 - 95; http://dx.doi.org/10.1083/jcb.200711165; PMID: 18474622
   PubMed Web of Science ®Google Scholar
• Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev 2011; 91:151 - 75; http://dx.doi.org/10.1152/physrev.00003.2008; PMID: 21248165
   PubMed Web of Science ®Google Scholar
• Fasano A, Not T, Wang W, Uzzau S, Berti I, Tommasini A, Goldblum SE. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 2000; 355:1518 - 9; http://dx.doi.org/10.1016/S0140-6736(00)02169-3; PMID: 10801176
   PubMed Web of Science ®Google Scholar
• Sapone A, de Magistris L, Pietzak M, Clemente MG, Tripathi A, Cucca F, Lampis R, Kryszak D, Cartenì M, Generoso M, et al. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes 2006; 55:1443 - 9; http://dx.doi.org/10.2337/db05-1593; PMID: 16644703
   PubMed Web of Science ®Google Scholar
• Buhner S, Buning C, Genschel J, Kling K, Herrmann D, Dignass A, Kuechler I, Krueger S, Schmidt HH, Lochs H. Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD15 3020insC mutation?. Gut 2006; 55:342 - 7; http://dx.doi.org/10.1136/gut.2005.065557; PMID: 16000642
   PubMed Web of Science ®Google Scholar
• Peeters M, Geypens B, Claus D, Nevens H, Ghoos Y, Verbeke G, Baert F, Vermeire S, Vlietinck R, Rutgeerts P. Clustering of increased small intestinal permeability in families with Crohn’s disease. Gastroenterology 1997; 113:802 - 7; http://dx.doi.org/10.1016/S0016-5085(97)70174-4; PMID: 9287971
   PubMed Web of Science ®Google Scholar
• Teahon K, Smethurst P, Levi AJ, Menzies IS, Bjarnason I. Intestinal permeability in patients with Crohn’s disease and their first degree relatives. Gut 1992; 33:320 - 3; http://dx.doi.org/10.1136/gut.33.3.320; PMID: 1568650
   PubMed Web of Science ®Google Scholar
• Büning C, Geissler N, Prager M, Sturm A, Baumgart DC, Büttner J, Bühner S, Haas V, Lochs H. Increased small intestinal permeability in ulcerative colitis: rather genetic than environmental and a risk factor for extensive disease?. Inflamm Bowel Dis 2012; 18:1932 - 9; http://dx.doi.org/10.1002/ibd.22909; PMID: 22344959
   PubMed Web of Science ®Google Scholar
• Gerova VA, Stoynov SG, Katsarov DS, Svinarov DA. Increased intestinal permeability in inflammatory bowel diseases assessed by iohexol test. World J Gastroenterol 2011; 17:2211 - 5; PMID: 21633531
   PubMed Web of Science ®Google Scholar
• Wyatt J, Vogelsang H, Hübl W, Waldhöer T, Lochs H. Intestinal permeability and the prediction of relapse in Crohn’s disease. Lancet 1993; 341:1437 - 9; http://dx.doi.org/10.1016/0140-6736(93)90882-H; PMID: 8099141
   PubMed Web of Science ®Google Scholar
• Ng SC, Tang W, Ching JY, Wong M, Chow CM, Hui AJ, Wong TC, Leung VK, Tsang SW, Yu HH, et al, Asia–Pacific Crohn’s and Colitis Epidemiologic Study (ACCESS) Study Group. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn’s and colitis epidemiology study. Gastroenterology 2013; 145:158 - 65, e2; http://dx.doi.org/10.1053/j.gastro.2013.04.007; PMID: 23583432
   PubMed Web of Science ®Google Scholar
• Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142:46 - 54, e42, quiz e30; http://dx.doi.org/10.1053/j.gastro.2011.10.001; PMID: 22001864
   PubMed Web of Science ®Google Scholar
• Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003; 3:521 - 33; http://dx.doi.org/10.1038/nri1132; PMID: 12876555
   PubMed Web of Science ®Google Scholar
• Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448:427 - 34; http://dx.doi.org/10.1038/nature06005; PMID: 17653185
   PubMed Web of Science ®Google Scholar
• Madsen KL, Malfair D, Gray D, Doyle JS, Jewell LD, Fedorak RN. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm Bowel Dis 1999; 5:262 - 70; http://dx.doi.org/10.1097/00054725-199911000-00004; PMID: 10579119
   PubMed Web of Science ®Google Scholar
• Irvine EJ, Marshall JK. Increased intestinal permeability precedes the onset of Crohn’s disease in a subject with familial risk. Gastroenterology 2000; 119:1740 - 4; http://dx.doi.org/10.1053/gast.2000.20231; PMID: 11113095
   PubMed Web of Science ®Google Scholar
• Baudry B, Fasano A, Ketley J, Kaper JB. Cloning of a gene (zot) encoding a new toxin produced by Vibrio cholerae. Infect Immun 1992; 60:428 - 34; PMID: 1730472
   PubMed Web of Science ®Google Scholar
• Fasano A, Baudry B, Pumplin DW, Wasserman SS, Tall BD, Ketley JM, Kaper JB. Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proc Natl Acad Sci U S A 1991; 88:5242 - 6; http://dx.doi.org/10.1073/pnas.88.12.5242; PMID: 2052603
   PubMed Web of Science ®Google Scholar
• Uzzau S, Cappuccinelli P, Fasano A. Expression of Vibrio cholerae zonula occludens toxin and analysis of its subcellular localization. Microb Pathog 1999; 27:377 - 85; http://dx.doi.org/10.1006/mpat.1999.0312; PMID: 10588910
   PubMed Web of Science ®Google Scholar
• Di Pierro M, Lu R, Uzzau S, Wang W, Margaretten K, Pazzani C, Maimone F, Fasano A. Zonula occludens toxin structure-function analysis. Identification of the fragment biologically active on tight junctions and of the zonulin receptor binding domain. J Biol Chem 2001; 276:19160 - 5; http://dx.doi.org/10.1074/jbc.M009674200; PMID: 11278543
   PubMed Web of Science ®Google Scholar
• Fasano A, Uzzau S, Fiore C, Margaretten K. The enterotoxic effect of zonula occludens toxin on rabbit small intestine involves the paracellular pathway. Gastroenterology 1997; 112:839 - 46; http://dx.doi.org/10.1053/gast.1997.v112.pm9041245; PMID: 9041245
   PubMed Web of Science ®Google Scholar
• Song KH, Fasano A, Eddington ND. Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A. Int J Pharm 2008; 351:8 - 14; http://dx.doi.org/10.1016/j.ijpharm.2007.09.011; PMID: 17954018
   PubMed Web of Science ®Google Scholar
• Fasano A, Uzzau S. Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model. J Clin Invest 1997; 99:1158 - 64; http://dx.doi.org/10.1172/JCI119271; PMID: 9077522
   PubMed Web of Science ®Google Scholar
• Fasano A, Fiorentini C, Donelli G, Uzzau S, Kaper JB, Margaretten K, Ding X, Guandalini S, Comstock L, Goldblum SE. Zonula occludens toxin modulates tight junctions through protein kinase C-dependent actin reorganization, in vitro. J Clin Invest 1995; 96:710 - 20; http://dx.doi.org/10.1172/JCI118114; PMID: 7635964
   PubMed Web of Science ®Google Scholar
• Wang W, Uzzau S, Goldblum SE, Fasano A. Human zonulin, a potential modulator of intestinal tight junctions. J Cell Sci 2000; 113:4435 - 40; PMID: 11082037
   PubMed Web of Science ®Google Scholar
• Watts T, Berti I, Sapone A, Gerarduzzi T, Not T, Zielke R, Fasano A. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc Natl Acad Sci U S A 2005; 102:2916 - 21; http://dx.doi.org/10.1073/pnas.0500178102; PMID: 15710870
   PubMed Web of Science ®Google Scholar
• Arrieta MC, Madsen K, Doyle J, Meddings J. Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse. Gut 2009; 58:41 - 8; http://dx.doi.org/10.1136/gut.2008.150888; PMID: 18829978
   PubMed Web of Science ®Google Scholar
• Paterson BM, Lammers KM, Arrieta MC, Fasano A, Meddings JB. The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study. Aliment Pharmacol Ther 2007; 26:757 - 66; http://dx.doi.org/10.1111/j.1365-2036.2007.03413.x; PMID: 17697209
   PubMed Web of Science ®Google Scholar
• Leffler DA, Kelly CP, Abdallah HZ, Colatrella AM, Harris LA, Leon F, Arterburn LA, Paterson BM, Lan ZH, Murray JA. A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge. Am J Gastroenterol 2012; 107:1554 - 62; http://dx.doi.org/10.1038/ajg.2012.211; PMID: 22825365
   PubMed Web of Science ®Google Scholar
• Gopalakrishnan S, Durai M, Kitchens K, Tamiz AP, Somerville R, Ginski M, Paterson BM, Murray JA, Verdu EF, Alkan SS, et al. Larazotide acetate regulates epithelial tight junctions in vitro and in vivo. Peptides 2012; 35:86 - 94; http://dx.doi.org/10.1016/j.peptides.2012.02.015; PMID: 22401908
   PubMed Web of Science ®Google Scholar
• Kelly CP, Green PH, Murray JA, Dimarino A, Colatrella A, Leffler DA, Alexander T, Arsenescu R, Leon F, Jiang JG, et al, Larazotide Acetate Celiac Disease Study Group. Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study. Aliment Pharmacol Ther 2013; 37:252 - 62; http://dx.doi.org/10.1111/apt.12147; PMID: 23163616
   PubMed Web of Science ®Google Scholar
• Goldblum SE, Rai U, Tripathi A, Thakar M, De Leo L, Di Toro N, Not T, Ramachandran R, Puche AC, Hollenberg MD, et al. The active Zot domain (aa 288-293) increases ZO-1 and myosin 1C serine/threonine phosphorylation, alters interaction between ZO-1 and its binding partners, and induces tight junction disassembly through proteinase activated receptor 2 activation. FASEB J 2011; 25:144 - 58; http://dx.doi.org/10.1096/fj.10-158972; PMID: 20852064
   PubMed Web of Science ®Google Scholar
• Gopalakrishnan S, Pandey N, Tamiz AP, Vere J, Carrasco R, Somerville R, Tripathi A, Ginski M, Paterson BM, Alkan SS. Mechanism of action of ZOT-derived peptide AT-1002, a tight junction regulator and absorption enhancer. Int J Pharm 2009; 365:121 - 30; http://dx.doi.org/10.1016/j.ijpharm.2008.08.047; PMID: 18832018
   PubMed Web of Science ®Google Scholar
• Li M, Oliver E, Kitchens KM, Vere J, Alkan SS, Tamiz AP. Structure-activity relationship studies of permeability modulating peptide AT-1002. Bioorg Med Chem Lett 2008; 18:4584 - 6; http://dx.doi.org/10.1016/j.bmcl.2008.07.028; PMID: 18667315
   PubMed Web of Science ®Google Scholar
• Song KH, Eddington ND. The impact of AT1002 on the delivery of ritonavir in the presence of bioadhesive polymer, carrageenan. Arch Pharm Res 2012; 35:937 - 43; http://dx.doi.org/10.1007/s12272-012-0520-1; PMID: 22644862
   PubMed Web of Science ®Google Scholar
• El Asmar R, Panigrahi P, Bamford P, Berti I, Not T, Coppa GV, Catassi C, Fasano A. Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. Gastroenterology 2002; 123:1607 - 15; http://dx.doi.org/10.1053/gast.2002.36578; PMID: 12404235
   PubMed Web of Science ®Google Scholar
• Clemente MG, De Virgiliis S, Kang JS, Macatagney R, Musu MP, Di Pierro MR, Drago S, Congia M, Fasano A. Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut 2003; 52:218 - 23; http://dx.doi.org/10.1136/gut.52.2.218; PMID: 12524403
   PubMed Web of Science ®Google Scholar
• Tripathi A, Lammers KM, Goldblum S, Shea-Donohue T, Netzel-Arnett S, Buzza MS, Antalis TM, Vogel SN, Zhao A, Yang S, et al. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci U S A 2009; 106:16799 - 804; http://dx.doi.org/10.1073/pnas.0906773106; PMID: 19805376
   PubMed Web of Science ®Google Scholar
• Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R. Proteinase-activated receptors. Pharmacol Rev 2001; 53:245 - 82; PMID: 11356985
   PubMed Web of Science ®Google Scholar
• Bueno L, Fioramonti J. Protease-activated receptor 2 and gut permeability: a review. Neurogastroenterol Motil 2008; 20:580 - 7; http://dx.doi.org/10.1111/j.1365-2982.2008.01139.x; PMID: 18482083
   PubMed Web of Science ®Google Scholar
• Tripathi A, Lammers KM, Goldblum S, Shea-Donohue T, Netzel-Arnett S, Buzza MS, Antalis TM, Vogel SN, Zhao A, Yang S, et al. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci U S A 2009; 106:16799 - 804; http://dx.doi.org/10.1073/pnas.0906773106; PMID: 19805376
   PubMed Web of Science ®Google Scholar
• Fernández-Blanco JA, Hollenberg MD, Martínez V, Vergara P. PAR-2-mediated control of barrier function and motility differs between early and late phases of postinfectious gut dysfunction in the rat. Am J Physiol Gastrointest Liver Physiol 2013; 304:G390 - 400; http://dx.doi.org/10.1152/ajpgi.00387.2012; PMID: 23238933
   PubMed Web of Science ®Google Scholar
• Van Itallie CM, Holmes J, Bridges A, Gookin JL, Coccaro MR, Proctor W, Colegio OR, Anderson JM. The density of small tight junction pores varies among cell types and is increased by expression of claudin-2. J Cell Sci 2008; 121:298 - 305; http://dx.doi.org/10.1242/jcs.021485; PMID: 18198187
   PubMed Web of Science ®Google Scholar
• Watson CJ, Hoare CJ, Garrod DR, Carlson GL, Warhurst G. Interferon-gamma selectively increases epithelial permeability to large molecules by activating different populations of paracellular pores. J Cell Sci 2005; 118:5221 - 30; http://dx.doi.org/10.1242/jcs.02630; PMID: 16249235
   PubMed Web of Science ®Google Scholar
• Maeda N, Yang F, Barnett DR, Bowman BH, Smithies O. Duplication within the haptoglobin Hp2 gene. Nature 1984; 309:131 - 5; http://dx.doi.org/10.1038/309131a0; PMID: 6325933
   PubMed Web of Science ®Google Scholar
• Levy AP, Asleh R, Blum S, Levy NS, Miller-Lotan R, Kalet-Litman S, Anbinder Y, Lache O, Nakhoul FM, Asaf R, et al. Haptoglobin: basic and clinical aspects. Antioxid Redox Signal 2010; 12:293 - 304; http://dx.doi.org/10.1089/ars.2009.2793; PMID: 19659435
   PubMed Web of Science ®Google Scholar
• Koch W, Latz W, Eichinger M, Roguin A, Levy AP, Schömig A, Kastrati A. Genotyping of the common haptoglobin Hp 1/2 polymorphism based on PCR. Clin Chem 2002; 48:1377 - 82; PMID: 12194911
   PubMed Web of Science ®Google Scholar
• Soejima M, Koda Y. TaqMan-based real-time PCR for genotyping common polymorphisms of haptoglobin (HP1 and HP2). Clin Chem 2008; 54:1908 - 13; http://dx.doi.org/10.1373/clinchem.2008.113126; PMID: 18787013
   PubMed Web of Science ®Google Scholar
• Sadrzadeh SM, Bozorgmehr J. Haptoglobin phenotypes in health and disorders. Am J Clin Pathol 2004; 121:Suppl S97 - 104; PMID: 15298155
   PubMedGoogle Scholar
• Levy AP, Hochberg I, Jablonski K, Resnick HE, Lee ET, Best L, Howard BV, Strong Heart Study. Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study. J Am Coll Cardiol 2002; 40:1984 - 90; http://dx.doi.org/10.1016/S0735-1097(02)02534-2; PMID: 12475459
   PubMed Web of Science ®Google Scholar
• Suleiman M, Aronson D, Asleh R, Kapeliovich MR, Roguin A, Meisel SR, Shochat M, Sulieman A, Reisner SA, Markiewicz W, et al. Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction. Diabetes 2005; 54:2802 - 6; http://dx.doi.org/10.2337/diabetes.54.9.2802; PMID: 16123372
   PubMed Web of Science ®Google Scholar
• Galicia G, Maes W, Verbinnen B, Kasran A, Bullens D, Arredouani M, Ceuppens JL. Haptoglobin deficiency facilitates the development of autoimmune inflammation. Eur J Immunol 2009; 39:3404 - 12; http://dx.doi.org/10.1002/eji.200939291; PMID: 19795414
   PubMed Web of Science ®Google Scholar
• Van Vlierberghe H, Langlois M, Delanghe J. Haptoglobin polymorphisms and iron homeostasis in health and in disease. Clin Chim Acta 2004; 345:35 - 42; http://dx.doi.org/10.1016/j.cccn.2004.03.016; PMID: 15193975
   PubMed Web of Science ®Google Scholar
• Arredouani MS, Kasran A, Vanoirbeek JA, Berger FG, Baumann H, Ceuppens JL. Haptoglobin dampens endotoxin-induced inflammatory effects both in vitro and in vivo. Immunology 2005; 114:263 - 71; http://dx.doi.org/10.1111/j.1365-2567.2004.02071.x; PMID: 15667571
   PubMed Web of Science ®Google Scholar
• Arredouani M, Matthijs P, Van Hoeyveld E, Kasran A, Baumann H, Ceuppens JL, Stevens E. Haptoglobin directly affects T cells and suppresses T helper cell type 2 cytokine release. Immunology 2003; 108:144 - 51; http://dx.doi.org/10.1046/j.1365-2567.2003.01569.x; PMID: 12562322
   PubMed Web of Science ®Google Scholar
• Arredouani M, Matthys P, Kasran A, Baumann H, Ceuppen JL. Haptoglobin and the Th1/Th2 balance: hints from in vitro and in vivo studies. Redox Rep 2001; 6:369 - 71; http://dx.doi.org/10.1179/135100001101536481; PMID: 11865978
   PubMed Web of Science ®Google Scholar
• Guetta J, Strauss M, Levy NS, Fahoum L, Levy AP. Haptoglobin genotype modulates the balance of Th1/Th2 cytokines produced by macrophages exposed to free hemoglobin. Atherosclerosis 2007; 191:48 - 53; http://dx.doi.org/10.1016/j.atherosclerosis.2006.04.032; PMID: 16820150
   PubMed Web of Science ®Google Scholar
• Yang F, Linehan LA, Friedrichs WE, Lalley PA, Sakaguchi AY, Bowman BH. Characterization of the mouse haptoglobin gene. Genomics 1993; 18:374 - 80; http://dx.doi.org/10.1006/geno.1993.1478; PMID: 8288241
   PubMed Web of Science ®Google Scholar
• Miller-Lotan R, Miller B, Nakhoul F, Aronson D, Asaf R, Levy AP. Retinal capillary basement membrane thickness in diabetic mice genetically modified at the haptoglobin locus. Diabetes Metab Res Rev 2007; 23:152 - 6; http://dx.doi.org/10.1002/dmrr.654; PMID: 16742000
   PubMed Web of Science ®Google Scholar
• Márquez L, Shen C, Cleynen I, De Hertogh G, Van Steen K, Machiels K, Perrier C, Ballet V, Organe S, Ferrante M, et al. Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitis. Gut 2012; 61:528 - 34; http://dx.doi.org/10.1136/gut.2011.240978; PMID: 21708824
   PubMed Web of Science ®Google Scholar
• Dayan L, Levy AP, Blum S, Miller-Lotan R, Melman U, Alshiek J, Jacob G. Haptoglobin genotype and endothelial function in diabetes mellitus: a pilot study. Eur J Appl Physiol 2009; 106:639 - 44; http://dx.doi.org/10.1007/s00421-009-1048-z; PMID: 19347351
   PubMed Web of Science ®Google Scholar
• Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996; 42:1589 - 600; PMID: 8855140
   PubMed Web of Science ®Google Scholar
• Pavón EJ, Muñoz P, Lario A, Longobardo V, Carrascal M, Abián J, Martin AB, Arias SA, Callejas-Rubio JL, Sola R, et al. Proteomic analysis of plasma from patients with systemic lupus erythematosus: increased presence of haptoglobin alpha2 polypeptide chains over the alpha1 isoforms. Proteomics 2006; 6:Suppl 1 S282 - 92; http://dx.doi.org/10.1002/pmic.200500404; PMID: 16544281
   PubMedGoogle Scholar
• Maza I, Miller-Lotan R, Levy AP, Nesher S, Karban A, Eliakim R. The association of Haptoglobin polymorphism with Crohn’s disease in Israel. J Crohns Colitis 2008; 2:214 - 8; http://dx.doi.org/10.1016/j.crohns.2008.03.005; PMID: 21172213
   PubMed Web of Science ®Google Scholar
• Papp M, Lakatos PL, Palatka K, Foldi I, Udvardy M, Harsfalvi J, Tornai I, Vitalis Z, Dinya T, Kovacs A, et al, Hungarian IBD Study Group. Haptoglobin polymorphisms are associated with Crohn’s disease, disease behavior, and extraintestinal manifestations in Hungarian patients. Dig Dis Sci 2007; 52:1279 - 84; http://dx.doi.org/10.1007/s10620-006-9615-1; PMID: 17357835
   PubMed Web of Science ®Google Scholar
• Anderson CA, Boucher G, Lees CW, Franke A, D’Amato M, Taylor KD, Lee JC, Goyette P, Imielinski M, Latiano A, et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 2011; 43:246 - 52; http://dx.doi.org/10.1038/ng.764; PMID: 21297633
   PubMed Web of Science ®Google Scholar
• Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, Brant SR, Silverberg MS, Taylor KD, Barmada MM, et al, NIDDK IBD Genetics Consortium, Belgian-French IBD Consortium, Wellcome Trust Case Control Consortium. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat Genet 2008; 40:955 - 62; http://dx.doi.org/10.1038/ng.175; PMID: 18587394
   PubMed Web of Science ®Google Scholar
• Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T, Lees CW, Balschun T, Lee J, Roberts R, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat Genet 2010; 42:1118 - 25; http://dx.doi.org/10.1038/ng.717; PMID: 21102463
   PubMed Web of Science ®Google Scholar
• Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, et al, International IBD Genetics Consortium (IIBDGC). Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491:119 - 24; http://dx.doi.org/10.1038/nature11582; PMID: 23128233
   PubMed Web of Science ®Google Scholar
• Cho JH, Nicolae DL, Gold LH, Fields CT, LaBuda MC, Rohal PM, Pickles MR, Qin L, Fu Y, Mann JS, et al. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci U S A 1998; 95:7502 - 7; http://dx.doi.org/10.1073/pnas.95.13.7502; PMID: 9636179
   PubMed Web of Science ®Google Scholar
• Williams CN, Kocher K, Lander ES, Daly MJ, Rioux JD. Using a genome-wide scan and meta-analysis to identify a novel IBD locus and confirm previously identified IBD loci. Inflamm Bowel Dis 2002; 8:375 - 81; http://dx.doi.org/10.1097/00054725-200211000-00001; PMID: 12454612
   PubMed Web of Science ®Google Scholar
• van Heel DA, Fisher SA, Kirby A, Daly MJ, Rioux JD, Lewis CM, Genome Scan Meta-Analysis Group of the IBD International Genetics Consortium. Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum Mol Genet 2004; 13:763 - 70; http://dx.doi.org/10.1093/hmg/ddh090; PMID: 14976156
   PubMed Web of Science ®Google Scholar
• Tabbara IA. Hemolytic anemias. Diagnosis and management. Med Clin North Am 1992; 76:649 - 68; PMID: 1578962
   PubMed Web of Science ®Google Scholar
• Morimatsu M, Syuto B, Shimada N, Fujinaga T, Yamamoto S, Saito M, Naiki M. Isolation and characterization of bovine haptoglobin from acute phase sera. J Biol Chem 1991; 266:11833 - 7; PMID: 1904872
   PubMed Web of Science ®Google Scholar
• Lubega J, Davies TJ. A comparison of serum mucoprotein with serum alpha 1 acid glycoprotein, haptoglobin, and alpha 1 antitrypsin assays in monitoring inflammatory bowel disease. Clin Chim Acta 1990; 188:59 - 69; http://dx.doi.org/10.1016/0009-8981(90)90146-J; PMID: 2347083
   PubMed Web of Science ®Google Scholar
• Fasano A, Catassi C. Clinical practice. Celiac disease. N Engl J Med 2012; 367:2419 - 26; http://dx.doi.org/10.1056/NEJMcp1113994; PMID: 23252527
   PubMed Web of Science ®Google Scholar
• Schulzke JD, Bentzel CJ, Schulzke I, Riecken EO, Fromm M. Epithelial tight junction structure in the jejunum of children with acute and treated celiac sprue. Pediatr Res 1998; 43:435 - 41; http://dx.doi.org/10.1203/00006450-199804000-00001; PMID: 9544995
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Peters TJ, Veall N. A persistent defect in intestinal permeability in coeliac disease demonstrated by a 51Cr-labelled EDTA absorption test. Lancet 1983; 1:323 - 5; http://dx.doi.org/10.1016/S0140-6736(83)91628-8; PMID: 6130333
   PubMed Web of Science ®Google Scholar
• Drago S, El Asmar R, Di Pierro M, Grazia Clemente M, Tripathi A, Sapone A, Thakar M, Iacono G, Carroccio A, D’Agate C, et al. Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scand J Gastroenterol 2006; 41:408 - 19; http://dx.doi.org/10.1080/00365520500235334; PMID: 16635908
   PubMed Web of Science ®Google Scholar
• Lammers KM, Lu R, Brownley J, Lu B, Gerard C, Thomas K, Rallabhandi P, Shea-Donohue T, Tamiz A, Alkan S, et al. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 2008; 135:194 - 204, e3; http://dx.doi.org/10.1053/j.gastro.2008.03.023; PMID: 18485912
   PubMed Web of Science ®Google Scholar
• Kelly CP, Green PH, Murray JA, Dimarino A, Colatrella A, Leffler DA, Alexander T, Arsenescu R, Leon F, Jiang JG, et al, Larazotide Acetate Celiac Disease Study Group. Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study. Aliment Pharmacol Ther 2013; 37:252 - 62; http://dx.doi.org/10.1111/apt.12147; PMID: 23163616
   PubMed Web of Science ®Google Scholar
• Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, Doyle J, Jewell L, De Simone C. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001; 121:580 - 91; http://dx.doi.org/10.1053/gast.2001.27224; PMID: 11522742
   PubMed Web of Science ®Google Scholar
• Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75:263 - 74; http://dx.doi.org/10.1016/0092-8674(93)80068-P; PMID: 8402911
   PubMed Web of Science ®Google Scholar
• Madsen KL, Malfair D, Gray D, Doyle JS, Jewell LD, Fedorak RN. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm Bowel Dis 1999; 5:262 - 70; http://dx.doi.org/10.1097/00054725-199911000-00004; PMID: 10579119
   PubMed Web of Science ®Google Scholar
• Visser JT, Lammers K, Hoogendijk A, Boer MW, Brugman S, Beijer-Liefers S, Zandvoort A, Harmsen H, Welling G, Stellaard F, et al. Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone BioBreeding rat. Diabetologia 2010; 53:2621 - 8; http://dx.doi.org/10.1007/s00125-010-1903-9; PMID: 20853098
   PubMed Web of Science ®Google Scholar
• Moreno-Navarrete JM, Sabater M, Ortega F, Ricart W, Fernández-Real JM. Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PLoS One 2012; 7:e37160; http://dx.doi.org/10.1371/journal.pone.0037160; PMID: 22629362
   PubMed Web of Science ®Google Scholar
• Zak-Gołąb A, Kocełak P, Aptekorz M, Zientara M, Juszczyk L, Martirosian G, Chudek J, Olszanecka-Glinianowicz M. Gut microbiota, microinflammation, metabolic profile, and zonulin concentration in obese and normal weight subjects. Int J Endocrinol 2013; 2013:674106; http://dx.doi.org/10.1155/2013/674106; PMID: 23970898
   PubMed Web of Science ®Google Scholar
• Klaus DA, Motal MC, Burger-Klepp U, Marschalek C, Schmidt EM, Lebherz-Eichinger D, Krenn CG, Roth GA. Increased plasma zonulin in patients with sepsis. Biochem Med (Zagreb) 2013; 23:107 - 11; http://dx.doi.org/10.11613/BM.2013.013; PMID: 23457771
   PubMed Web of Science ®Google Scholar
• Rittirsch D, Flierl MA, Nadeau BA, Day DE, Huber-Lang MS, Grailer JJ, Zetoune FS, Andjelkovic AV, Fasano A, Ward PA. Zonulin as prehaptoglobin2 regulates lung permeability and activates the complement system. Am J Physiol Lung Cell Mol Physiol 2013; 304:L863 - 72; http://dx.doi.org/10.1152/ajplung.00196.2012; PMID: 23564505
   PubMed Web of Science ®Google Scholar